2017
DOI: 10.1373/clinchem.2016.262659
|View full text |Cite
|
Sign up to set email alerts
|

Immediate Rule-Out of Acute Myocardial Infarction Using Electrocardiogram and Baseline High-Sensitivity Troponin I

Abstract: www.clinicaltrials.gov (NCT02355457).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
41
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 59 publications
(42 citation statements)
references
References 19 publications
1
41
0
Order By: Relevance
“…[13,16] In summary, 1,641 patients with suspected AMI presenting to the ED or chest pain unit of the University Hospital Hamburg-Eppendorf between 19.07.2013 and 01.04.2016 were included. All individuals were above the age of 18 and gave written informed consent.…”
Section: Methodsmentioning
confidence: 99%
“…[13,16] In summary, 1,641 patients with suspected AMI presenting to the ED or chest pain unit of the University Hospital Hamburg-Eppendorf between 19.07.2013 and 01.04.2016 were included. All individuals were above the age of 18 and gave written informed consent.…”
Section: Methodsmentioning
confidence: 99%
“…Accumulating evidence summarised in a recent editorial18 and based on two meta-analyses19 20 on more than 9000 patients each, and individual observational cohorts21 22 support the use of a single admission hsTnT at the LoB or the LoD to rule-out MI. Correspondingly, several studies demonstrate excellent instant rule-out of MI using hsTnI at cut-offs at or close to the LoD including the UTROPIA study23 (Use of TROPonin In Acute coronary syndromes) in the USA, High-STEACS Study24 in Scotland, a High-STEACS substudy,25 the Biomarkers in Acute Cardiac Care (BACC) Study26 in Germany and a pooled analysis of five international (Australia, New Zealand and England) observational cohort studies 27. As an alternative to the single hsTn value-based instant rule-out of MI, the dual marker strategy (DMS) based on copeptin and cTn/hsTn has been recommended by ESC guidelines as an alternative based on numerous clinical trials3 and two meta-analyses, and because DMS has been demonstrated in a large randomised intervention trial28 to allow an earlier discharge that is at least as safe as a standard diagnostic strategy.…”
Section: Introductionmentioning
confidence: 99%
“…A final clinical diagnosis of acute myocardial infarction (AMI) was established for 45 of the 426 patients (10.5%), with a significant difference ( p < 0.05) between females (9.2%) and males (11.6%); these data are in lower end of the range (9.2–23.2%) reported by other studies [714]. The number and rates of different diagnoses are reported in Table 3; the most frequent ones being nonspecific chest pain (92 cases) and neurological diseases (74, mostly syncope).…”
Section: Resultsmentioning
confidence: 82%
“…Indeed some recent publications have documented this approach as being clinically accurate, especially for ruling out [1214, 16]. Even if in our experience the second draw was obtained after 3 hours, we tried to apply this “accelerated” algorithm by using only the results obtained by the hsTnI assay at baseline.…”
Section: Resultsmentioning
confidence: 99%